In states of androgen excess, such as PCOS, this shift can attenuate hyperandrogenemia and improve menstrual cyclicity and ovulatory function, with concurrent gains in insulin sensitivity [81]. The gene discussed is INS; the disease is polycystic ovary syndrome.